{"nct_id":"NCT02381314","title":"Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2015-03-26","start_date_type":"ACTUAL","primary_completion_date":"2017-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MGNX"]}